Suchergebnisse - "HCC"

Long-term risk of HCC in a DAA-treated national hepatitis C cohort, and a proposed risk score

Autoren: Lybeck, Charlotte Bruce, Daniel Szulkin, Robert et al.

Quelle: Infectious Diseases. 57(3):211-233

Schlagwörter: DAA, HCC, Viral hepatitis, risk score, surveillance

Dateibeschreibung: print

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-116332
https://doi.org/10.1080/23744235.2024.2403703

Small nucleolar RNA expression profiles: a potential prognostic biomarker for non-viral Hepatocellular carcinoma

Autoren: Mallela, Venkata Ramana Kasi, Phanindra Babu Shetti, Dattatrya et al.

Quelle: Non-coding RNA Research. 9(4):1133-1139

Schlagwörter: Hepatocellular carcinoma, Non-viral HCC snoRA47 and snoRD126, Prognostic marker, Small nucleolar RNA

Dateibeschreibung: electronic

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-227331
https://doi.org/10.1016/j.ncrna.2024.06.009

Elevation of S2-bound a1-acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma

Autoren: Oltmanns, Carlos Bremer, Birgit Kusche, Laura et al.

Quelle: Journal of Viral Hepatitis. 31(7):383-390

Schlagwörter: AST, biomarker, cancer, elastography, HBV, HCC, HCV, MASLD, S2-bound AGP, surveillance

Dateibeschreibung: electronic

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-202917
https://liu.diva-portal.org/smash/get/diva2:1853417/FULLTEXT01.pdf

Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis

Autoren: Nahon, Pierre Lusivika-Nzinga, Clovis Merle, Philippe et al.

Weitere Verfasser: Nahon, Pierre Lusivika-Nzinga, Clovis Merle, Philippe et al.

Quelle: Journal of Hepatology. 83:701-711

Schlagwörter: [SDV] Life Sciences [q-bio], SVR, noninvasive tests, HCV, surveillance, risk stratification, HCC

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40020929

Successful long-term survival following lipiodol chemoembolization for hepatocellular carcinoma in Alagille syndrome: A case report

Autoren: Imad Akasbi Ismail Chaouche Nizar El Bouardi et al.

Quelle: Radiol Case Rep
Radiology Case Reports, Vol 20, Iss 8, Pp 3879-3885 (2025)

Schlagwörter: Medical physics. Medical radiology. Nuclear medicine, R895-920, Case Report, HCC, Alagille syndrome, Lipiodol chemoembolization

Zugangs-URL: https://doaj.org/article/e318328df08b4793a8be6904785ed22a

Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study

Autoren: Ali Kaan Güren Hilal Polat Eyüp Çoban et al.

Weitere Verfasser: Ali Kaan Güren Hilal Polat Eyüp Çoban et al.

Quelle: Annals of Saudi Medicine, Vol 45, Iss 4, Pp 249-255 (2025)

Schlagwörter: DNAJB1-PRKACA, Gemcitabine-oxaliplatin, Medicine, Immunotherapy, Fibrolamellar HCC, Sorafenib

Zugangs-URL: https://doaj.org/article/dc971181e2914c4ea69a2daed95b3dfa

CDK4/6 inhibitor PD-0332991 suppresses hepatocarcinogenesis by inducing senescence of hepatic tumor-initiating cells

Autoren: Miaomiao Chen Wenjian Chen Shiwen Sun et al.

Quelle: J Adv Res
Journal of Advanced Research, Vol 73, Iss, Pp 357-373 (2025)

Schlagwörter: CDK4/6 inhibitors, Medicine (General), Q1-390, R5-920, Science (General), Basic and Biological Science, Tumor-initiating cells, HCC, Cellular senescence, Cyclin D-CDK4/6-INK4-Rb pathway

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39218249
https://doaj.org/article/cec1cfb0284f4ffba1081f3d78698005

Widening research horizons on metabolic dysfunction-associated steatotic liver disease and cancer

Autoren: Amedeo Lonardo Norbert Stefan Alessandro Mantovani

Quelle: Trends in Endocrinology & Metabolism. 36:610-613

Schlagwörter: MASLD, MASH, HCC

Dateibeschreibung: application/pdf

PolyIC as an adjuvant outperforms anti-VEGF in combination with anti-PD-L1 therapy in mouse liver tumor models

Autoren: Ji, Yichun Lu, Li-Chun Zhuang, Hao et al.

Quelle: Hepatology Communications. 9(9)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), 3204 Immunology (for-2020), Genetics (rcdc), Vaccine Related (rcdc), Liver Cancer (rcdc), Rare Diseases (rcdc), Colo-Rectal Cancer (rcdc), Immunization (rcdc), Digestive Diseases (rcdc), Cancer (rcdc), Immunotherapy (rcdc), Liver Disease (rcdc), 5.1 Pharmaceuticals (hrcs-rac), 6.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), Animals (mesh), Mice (mesh), Vascular Endothelial Growth Factor A (mesh), Immune Checkpoint Inhibitors (mesh), B7-H1 Antigen (mesh), Poly I-C (mesh), Liver Neoplasms (mesh), Disease Models, Animal (mesh), Cell Line, Tumor (mesh), Adjuvants, Immunologic (mesh), Mice, Inbred C57BL (mesh), Angiogenesis Inhibitors (mesh), CD8-Positive T-Lymphocytes (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), anti-PD-L1, anti-VEGF, HCC, immunomodulation, polyIC, CD8-Positive T-Lymphocytes (mesh), Cell Line, Tumor (mesh), Animals (mesh), Mice, Inbred C57BL (mesh), Mice (mesh), Liver Neoplasms (mesh), Disease Models, Animal (mesh), Angiogenesis Inhibitors (mesh), Vascular Endothelial Growth Factor A (mesh), Poly I-C (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Adjuvants, Immunologic (mesh), B7-H1 Antigen (mesh), Immune Checkpoint Inhibitors (mesh), HCC, anti-PD-L1, anti-VEGF, immunomodulation, polyIC, Animals (mesh), Mice (mesh), Vascular Endothelial Growth Factor A (mesh), Immune Checkpoint Inhibitors (mesh), B7-H1 Antigen (mesh), Poly I-C (mesh), Liver Neoplasms (mesh), Disease Models, Animal (mesh), Cell Line, Tumor (mesh), Adjuvants, Immunologic (mesh), Mice, Inbred C57BL (mesh), Angiogenesis Inhibitors (mesh), CD8-Positive T-Lymphocytes (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), 3202 Clinical sciences (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/9qt8v396
https://escholarship.org/content/qt9qt8v396/qt9qt8v396.pdf

Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Hepatocellular Carcinoma: A Review of Emerging Applications for Locoregional Therapy

Autoren: Li, Xinyi M Nguyen, Tu Sparks, Hiro D et al.

Quelle: Bioengineering. 12(8)

Schlagwörter: 40 Engineering (for-2020), 4003 Biomedical Engineering (for-2020), Liver Disease (rcdc), Clinical Research (rcdc), Biomedical Imaging (rcdc), Digestive Diseases (rcdc), Clinical Trials and Supportive Activities (rcdc), Rare Diseases (rcdc), Cancer (rcdc), Orphan Drug (rcdc), Liver Cancer (rcdc), Cancer (hrcs-hc), hepatocellular carcinoma (HCC), dynamic contrast-enhanced MRI (DCE-MRI), locoregional therapy, tumor perfusion, imaging biomarker, thermal ablation, transarterial chemoembolization (TACE), transarterial radioembolization (TARE), dynamic contrast-enhanced MRI (DCE-MRI), hepatocellular carcinoma (HCC), imaging biomarker, locoregional therapy, thermal ablation, transarterial chemoembolization (TACE), transarterial radioembolization (TARE), tumor perfusion, 4003 Biomedical engineering (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/6r16n5k9
https://escholarship.org/content/qt6r16n5k9/qt6r16n5k9.pdf

Advances in Hepatocellular Carcinoma: Molecular Insights, Histologic Subtypes, and Differential Diagnosis.

Autoren: Zheng, Wei Haw, Yulin Wang, Hanlin L

Schlagwörter: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Digestive Diseases, Liver Cancer, Cancer, Rare Diseases, Genetics, Precision Medicine, Liver Disease, 4.1 Discovery and preclinical testing of markers and technologies, 4.2 Evaluation of markers and technologies, Good Health and Well Being, HCA, HCC, HGDN, Hepatocellular carcinoma, biopsy, borderline hepatocellular neoplasm, hepatocellular adenoma, high-grade dysplastic nodule, molecular testing, subtypes, Clinical Sciences, Pathology, Clinical sciences

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/3b82q3kh
https://escholarship.org/content/qt3b82q3kh/qt3b82q3kh.pdf

Non-viral HCC miRNA profiling reveals miR-1972 as a potential positive prognostic marker

Autoren: Venkata Ramana Mallela Marie Rajtmajerová Esraa Ali et al.

Quelle: Non-coding RNA Research, Vol 15, Iss , Pp 100-107 (2025)

Schlagwörter: Hepatocellular carcinoma, HCC, Non-viral HCC, microRNA, miR-1972, Genetics, QH426-470

Dateibeschreibung: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2468054025000873; https://doaj.org/toc/2468-0540

Zugangs-URL: https://doaj.org/article/701336540adc4efeb41fbf7c8e8f6563

A wide scan of plasma proteins demonstrates thioredoxin reductase 1 as a potential new diagnostic biomarker for hepatocellular carcinoma

Autoren: Zenlander, Robin Fredolini, Claudia Schwenk, Jochen M. et al.

Quelle: Scandinavian Journal of Gastroenterology. 58(9):998-1008

Schlagwörter: HCC, Liver cancer, protein panel, screening, TXNRD1

Dateibeschreibung: print

Zugangs-URL: https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-338474
https://doi.org/10.1080/00365521.2023.2194008

Characterising spontaneous bacterial peritonitis in liver cirrhosis and hepatocellular carcinoma in southwestern Nigeria

Autoren: G. Adeyeye, Abosede T. Adeyemo, Adeyemi O. Adeyeye, Victor et al.

Quelle: Ghana Med J
Ghana Medical Journal; Vol. 59 No. 2 (2025); 52-59

Schlagwörter: Nigeria, spontaneous bacterial peritonitis, liver cirrhosis and HCC, Ile-Ife, Original Article, Prevalence

Dateibeschreibung: application/pdf

Zugangs-URL: https://www.ajol.info/index.php/gmj/article/view/298323

The oncogenic microRNA miR-222 promotes human LINE-1 retrotransposition

Autoren: Tomer Friehmann Yamama Abu Mohsen Yehuda Schlesinger et al.

Quelle: RNA Biol
RNA Biology, Vol 22, Iss 1, Pp 1-15 (2025)

Schlagwörter: microRNA, let-7, retrotransposon, Genetics, HCC, QH426-470, miR-222, Research Article

Zugangs-URL: https://doaj.org/article/5424b55849644d5e910c3c0a6ed1190d

Identification and validation of a ferroptosis-related long non-coding RNA signature as a prognostic biomarker for hepatocellular carcinoma

Autoren: Yu, Tingting Chen, Xiaoxiang Li, Shuo et al.

Quelle: J Gastrointest Oncol
Yu, T, Chen, X, Li, S, Ladekarl, M & Li, J 2025, 'Identification and validation of a ferroptosis-related long non-coding RNA signature as a prognostic biomarker for hepatocellular carcinoma', Journal of gastrointestinal oncology, vol. 16, no. 3, pp. 1092-1104. https://doi.org/10.21037/jgo-2025-360

Schlagwörter: LINC01063 oncogene, Original Article, prognostic signature, Hepatocellular carcinoma (HCC), long non-coding RNA (lncRNA), ferroptosis

Dateibeschreibung: application/pdf

Zugangs-URL: https://vbn.aau.dk/da/publications/bc4c1df0-426e-4505-9408-f951833be28e
https://doi.org/10.21037/jgo-2025-360
http://www.scopus.com/inward/record.url?scp=105009332765&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/794108086/Yu_et_al_2025_._Identification_and_validation_of_a_ferroptosis-related_long_non-coding_RNA_signature_as_a_prognostic_biomarker_for_hepatocellular_carcinoma.pdf

Nanomaterials Mediated Enhancement of CAR-T for HCC: Revolutionizing Immunotherapy Strategies

Autoren: Liu X Liu Y Zhao D et al.

Quelle: Int J Nanomedicine
International Journal of Nanomedicine, Vol Volume 20, Iss Issue 1, Pp 7489-7500 (2025)

Schlagwörter: Medicine (General), R5-920, Tumor microenvironment, Immunotherapy, Review, HCC, Nanomaterials, CAR-T

Zugangs-URL: https://doaj.org/article/7e0b7eb6738540bba7f9965c99926a8a

Unveiling the 'vessel-inside-vessel' phenomenon: A rare case of extensive portal vein tumor thrombosis in hepatocellular carcinoma

Autoren: Mohamed Fadil Hatim Essaber Asaad El Bakkari et al.

Quelle: Radiol Case Rep
Radiology Case Reports, Vol 20, Iss 6, Pp 2768-2771 (2025)

Schlagwörter: Medical physics. Medical radiology. Nuclear medicine, US, Portal vein, R895-920, Case Report, HCC, Metastasis, CT

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40165848
https://doaj.org/article/15103121b90f42a29a55b06345a19b55

Anti-PD-1 synergizes with RFA to suppress abscopal tumors and induce durable memory against recurrence in HCC

Autoren: Kai Lei Shuang Li Jiale Chen et al.

Quelle: Liver Res
Liver Research, Vol 9, Iss 2, Pp 132-143 (2025)

Schlagwörter: Anti-programmed cell death protein 1 (αPD-1), Radiofrequency ablation (RFA), Abscopal effect, Original Article, RC799-869, Hepatocellular carcinoma (HCC), Diseases of the digestive system. Gastroenterology

Zugangs-URL: https://doaj.org/article/753e9a6f3e6840ab8914bdb6ed22cf1f

Etiology of hepatocellular carcinoma may influence the pattern of progression under atezolizumab-bevacizumab

Autoren: Stefanini B. Piscaglia F. Marra F. et al.

Quelle: Liver Cancer

Schlagwörter: Etiology, HCC, MASLD, Pattern of progression, Research Article